Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Scoppetta

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
European Neurology|January 1, 1974
Long-term treatment of myasthenia gravis with alternate-day prednisone. Report on 15 patientsP Pinelli, P Tonali, C Scoppetta
Rivista Di Neurologia|November 1, 1976
[Electrophysiological observations in dystrophia myotonica and distal myopathy]C Messina, P Tonali, C Scoppetta
Minerva Medica|February 11, 1976
[Friedreich's disease, diabetes and pregnancy. Description of a case]E Moneta, A Cocchi, C Scoppetta
Rivista Di Neurologia|March 1, 1977
[EMG phasic suppressions and ponto-geniculo-occipital (PGO) activity: attempted study during human nocturnal sleep]G Mennuni, C Scoppetta, P Bergonzi
Rivista Di Neurologia|November 1, 1977
[Electrophysiological findings in myotonic dystrophy: repeated stimulations, conduction velocity, reflexes]C Messina, P Tonali, C Scoppetta
European Review for Medical and Pharmacological Sciences|May 21, 2020
Editorial - High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patientsC Scoppetta, G Di Gennaro, F Polverino
European Review for Medical and Pharmacological Sciences|January 28, 2021
Lethality rate of the two waves of the COVID-19 pandemic in ItalyC Scoppetta, S Casciato, G Di Gennaro
Muscle & Nerve|July 1, 1978
Pathogenesis of myasthenia gravisC Scoppetta, M L Vaccario, L Russo
European Review for Medical and Pharmacological Sciences|February 17, 2006
Selective serotonine reuptake inhibitors prevents emotional lability in healthy subjectsM Scoppetta, G Di Gennaro, C Scoppetta
European Review for Medical and Pharmacological Sciences|August 9, 2020
Speculative clues on Myasthenia gravis and COVID-19C Scoppetta, S Casciato, G Di Gennaro
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
European Neurology|January 1, 1974
Long-term treatment of myasthenia gravis with alternate-day prednisone. Report on 15 patientsP Pinelli, P Tonali, C Scoppetta
Rivista Di Neurologia|November 1, 1976
[Electrophysiological observations in dystrophia myotonica and distal myopathy]C Messina, P Tonali, C Scoppetta
Minerva Medica|February 11, 1976
[Friedreich's disease, diabetes and pregnancy. Description of a case]E Moneta, A Cocchi, C Scoppetta
Rivista Di Neurologia|March 1, 1977
[EMG phasic suppressions and ponto-geniculo-occipital (PGO) activity: attempted study during human nocturnal sleep]G Mennuni, C Scoppetta, P Bergonzi
Rivista Di Neurologia|November 1, 1977
[Electrophysiological findings in myotonic dystrophy: repeated stimulations, conduction velocity, reflexes]C Messina, P Tonali, C Scoppetta
European Review for Medical and Pharmacological Sciences|May 21, 2020
Editorial - High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patientsC Scoppetta, G Di Gennaro, F Polverino
European Review for Medical and Pharmacological Sciences|January 28, 2021
Lethality rate of the two waves of the COVID-19 pandemic in ItalyC Scoppetta, S Casciato, G Di Gennaro
Muscle & Nerve|July 1, 1978
Pathogenesis of myasthenia gravisC Scoppetta, M L Vaccario, L Russo
European Review for Medical and Pharmacological Sciences|February 17, 2006
Selective serotonine reuptake inhibitors prevents emotional lability in healthy subjectsM Scoppetta, G Di Gennaro, C Scoppetta
European Review for Medical and Pharmacological Sciences|August 9, 2020
Speculative clues on Myasthenia gravis and COVID-19C Scoppetta, S Casciato, G Di Gennaro
Pageof 8